CA2278452A1 - Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors) - Google Patents

Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors) Download PDF

Info

Publication number
CA2278452A1
CA2278452A1 CA002278452A CA2278452A CA2278452A1 CA 2278452 A1 CA2278452 A1 CA 2278452A1 CA 002278452 A CA002278452 A CA 002278452A CA 2278452 A CA2278452 A CA 2278452A CA 2278452 A1 CA2278452 A1 CA 2278452A1
Authority
CA
Canada
Prior art keywords
alkyl
compound
halogen
halo
topoisomerase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002278452A
Other languages
English (en)
French (fr)
Inventor
Leroy Fong Liu
Qun Sun
Edmond J. Lavoie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers, The State University of New Jersey
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2278452A1 publication Critical patent/CA2278452A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002278452A 1997-01-21 1998-01-21 Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors) Abandoned CA2278452A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/786,629 US5770617A (en) 1996-03-20 1997-01-21 Terbenzimidazoles useful as antifungal agents
US08/786,629 1997-01-21
PCT/US1998/001005 WO1998031673A1 (en) 1997-01-21 1998-01-21 Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors)

Publications (1)

Publication Number Publication Date
CA2278452A1 true CA2278452A1 (en) 1998-07-23

Family

ID=25139154

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002278452A Abandoned CA2278452A1 (en) 1997-01-21 1998-01-21 Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors)

Country Status (10)

Country Link
US (1) US5770617A (enExample)
EP (1) EP0960103A1 (enExample)
JP (1) JP2002513399A (enExample)
KR (1) KR20000070359A (enExample)
AU (1) AU746663B2 (enExample)
CA (1) CA2278452A1 (enExample)
IL (1) IL130572A0 (enExample)
NZ (1) NZ336606A (enExample)
PL (1) PL334662A1 (enExample)
WO (1) WO1998031673A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1299358A (zh) * 1997-12-31 2001-06-13 新泽西州州立大学(拉特格斯) 杂环拓扑异构酶毒性剂
IL137351A0 (en) 1998-02-12 2001-07-24 Univ Rutgers Heterocyclic topoisomerase poisons
WO2000076556A2 (en) * 1999-06-11 2000-12-21 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6740650B2 (en) 1999-10-29 2004-05-25 Rutgers, The State University Of New Jersey Heterocyclic cytotoxic agents
JP2004536034A (ja) 2001-01-08 2004-12-02 ネオルクス コーポレイション 治療的および診断的化合物、組成物および方法
AU2002363658B2 (en) * 2001-11-14 2008-09-11 Rutgers, The State University Solubilized topoisomerase poisons
CA2467279A1 (en) * 2001-11-14 2003-06-26 Edmond J. Lavoie Solubilized topoisomerase poison agents
ATE405568T1 (de) * 2001-11-14 2008-09-15 Univ Rutgers Cytotoxische mittel
DE60225943T2 (de) * 2001-11-14 2009-01-29 Rutgers, The State University Topoisomerase-giftmittel
EP1458416A1 (en) 2001-12-13 2004-09-22 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
AU2003268075A1 (en) * 2002-08-09 2004-02-25 Edmond J. Lavoie Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
US6992088B2 (en) * 2002-08-09 2006-01-31 Rutgers, The State University Of New Jersey Nitro and amino substituted heterocycles as topoisomerase I targeting agents
US6989387B2 (en) * 2002-08-09 2006-01-24 Rutgers, The State University Of New Jersey Nitro and amino substituted topoisomerase agents
AU2003290818A1 (en) * 2002-11-12 2004-06-03 Edmond J. Lavoie Topoisomerase-targeting agents
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
GB0821913D0 (en) 2008-12-02 2009-01-07 Price & Co Antibacterial compounds
JP5773888B2 (ja) 2009-03-06 2015-09-02 ラットガーズ，ザ・ステート・ユニバーシティ・オブ・ニュージャージー 癌治療に用いられるメチレンジオキシベンゾ［ｉ］フェナントリジン誘導体
WO2010127363A1 (en) 2009-05-01 2010-11-04 Rutgers, The State University Of New Jersey Toposiomerase inhibitors
CA2801274C (en) * 2010-06-01 2021-06-15 Summit Corporation Plc Compounds for the treatment of clostridium difficile-associated disease
US9920014B2 (en) 2013-09-19 2018-03-20 The Florida International University Board Of Trustees Selective inhibition of bacterial topoisomerase I
GB201506660D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
GB201506658D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
CA3011672C (en) 2016-01-23 2022-11-01 Vibha Tandon Broad spectrum antibacterial activity of bisbenzimidazoles targeting topoisomerase ia
EP3442979A4 (en) 2016-04-04 2019-12-18 Rutgers, the State University of New Jersey topoisomerase poisons
JP7267563B2 (ja) 2017-06-27 2023-05-02 株式会社Kyulux 発光材料、化合物、遅延蛍光体および発光素子
WO2019004254A1 (ja) 2017-06-27 2019-01-03 株式会社Ｋｙｕｌｕｘ 発光材料、化合物、遅延蛍光体および発光素子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2221248A1 (en) * 1995-05-17 1996-11-21 Leroy Fong Liu Tribenzimidazoles useful as topoisomerase i inhibitors
US5643935A (en) * 1995-06-07 1997-07-01 The University Of North Carolina At Chapel Hill Method of combatting infectious diseases using dicationic bis-benzimidazoles

Also Published As

Publication number Publication date
NZ336606A (en) 2001-04-27
PL334662A1 (en) 2000-03-13
IL130572A0 (en) 2000-06-01
JP2002513399A (ja) 2002-05-08
AU746663B2 (en) 2002-05-02
AU6132798A (en) 1998-08-07
US5770617A (en) 1998-06-23
EP0960103A1 (en) 1999-12-01
KR20000070359A (ko) 2000-11-25
WO1998031673A1 (en) 1998-07-23

Similar Documents

Publication Publication Date Title
US5770617A (en) Terbenzimidazoles useful as antifungal agents
WO1998031673A9 (en) Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors)
US5767142A (en) Trisbenzimidazoles useful as topoisomerase I inhibitors
US5948797A (en) Trisbenzimidazoles useful as topoisomerase I inhibitors
JP5266430B2 (ja) 金属酵素阻害化合物
CN105431418B (zh) 金属酶抑制剂化合物
AU2006201397A1 (en) Bacterial Gyrase Inhibitors and Uses Thereof
AU713317B2 (en) Trisbenzimidazoles useful as topoisomerase I inhibitors
CZ302374B6 (cs) Derivát 1,2-anelovaného chinolinu, zpusob a meziprodukt pro jeho prípravu a farmaceutický prostredek s jeho obsahem
CA2316223A1 (en) Hydrophilic coating for an intracorporeal medical device
JP2000504687A (ja) トポイソメラーゼインヒビターとしてのカラリン類似体
JP2011046745A (ja) ジャイレース阻害剤およびその用途
CA2316221A1 (en) Heterocyclic topoisomerase poisons
JP2002503653A (ja) 複素環式トポイソメラーゼ毒素
MXPA99006793A (es) Terbencimidazoles utiles para terapia medica(inhibidores de topoisomerasa)
CZ258999A3 (cs) Terbenzimidazoly a farmaceutický prostředek
Dyer et al. Synthesis of (E)-1-(5-chlorothien-2-yl)-2-(1H-imidazol-1-yl) ethanone 2, 6-dichlorophenylhydrazone hydrochloride, a novel, orally active antifungal agent
WO2000050419A1 (de) Substituierte bicyclische heterocyclen und deren verwendung als thrombininhibitoren
AU730456B2 (en) Use of trisbenzimidazoles as anti-fungal agents
KR20020072304A (ko) 헤테로사이클릭 아미드 유도체
MXPA97008822A (en) Tribencimidazoles useful as inhibitors of topoisomeras
JP2000072677A (ja) 抗真菌性組成物
Jee et al. STUDY ON MEDICINAL CHEMISTRY OF EMERGING BENZIMIDAZOLE NUCLEUS
MXPA00007838A (en) Heterocyclic topoisomerase poisons
CZ20002965A3 (cs) Benzimidazolové deriváty

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued